Shareholder rights litigation

Search documents
Cytokinetics, Inc. Class Action Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the CYTK Class Action Lawsuit
Prnewswire· 2025-09-25 00:37
Accessibility StatementSkip Navigation About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Attorney Advertising. Past results do not guarantee a similar outcome. SOURCE Robbins LLP WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? SAN DIEGO, Sept. 24, 2025 /PRNewswire/ -- ...
Fluor Corporation Class Action Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the FLR Class Action Lawsuit
Prnewswire· 2025-09-25 00:36
Core Viewpoint - A class action lawsuit has been filed against Fluor Corporation for allegedly misleading investors regarding its business prospects and financial guidance during a specific period in 2025 [1][2]. Group 1: Allegations and Financial Impact - The lawsuit claims that Fluor failed to disclose rising costs associated with key infrastructure projects due to subcontractor design errors, price increases, and scheduling delays [2]. - It is alleged that these issues, along with reduced capital spending from customers and economic uncertainty, significantly impacted Fluor's business and financial results [2]. - Following disappointing financial results for Q2 2025, Fluor revised its financial outlook for FY 2025, projecting adjusted EBITDA of $475 million to $525 million, down from a previous range of $575 million to $675 million, and adjusted EPS of $1.95 to $2.15, down from $2.25 to $2.75 [3]. Group 2: Stock Price Reaction - After the negative financial disclosures, Fluor's stock price dropped by $15.35 per share, or 27.04%, closing at $41.42 per share on August 1, 2025 [3]. Group 3: Class Action Participation - Shareholders interested in participating in the class action must submit their papers by November 14, 2025, to serve as lead plaintiff [4]. - Shareholders can remain absent class members if they choose not to participate in the case [4].
Do you own shares of KBR? Robbins LLP Informs Investors of the Jasper Therapeutics, Inc. Class Action Lawsuit
Prnewswire· 2025-09-20 12:00
Core Viewpoint - A class action lawsuit has been filed against Jasper Therapeutics, Inc. for allegedly misleading investors regarding the commercial prospects of its lead product candidate, briquilimab [1][2]. Group 1: Allegations - The lawsuit claims that Jasper Therapeutics failed to disclose critical information about its manufacturing controls and procedures, which were necessary to ensure compliance with cGMP regulations [2]. - The lack of proper controls increased the risk of confounding results in ongoing studies, negatively impacting the regulatory and commercial prospects of the company's products, including briquilimab [2]. - This situation heightened the likelihood of disruptive cost-reduction measures, leading to an overstatement of the company's business and financial prospects [2]. Group 2: Stock Price Impact - Following the revelation of these issues on July 7, 2025, Jasper's stock price plummeted by $3.73 per share, representing a 55.1% decline, closing at $3.04 per share [3]. Group 3: Class Action Participation - Shareholders who purchased Jasper Therapeutics securities between November 30, 2023, and July 3, 2025, may be eligible to participate in the class action [1][4]. - Interested shareholders can contact Robbins LLP to serve as lead plaintiff or remain as absent class members without participating in the case [4].
Do you own shares of KBR? Robbins LLP Informs Investors of the KBR, Inc. Class Action Lawsuit
Prnewswire· 2025-09-20 01:18
Group 1 - A class action has been filed against KBR, Inc. on behalf of investors who acquired its securities between May 6, 2025, and June 19, 2025 [1] - The allegations center around KBR's joint venture, HomeSafe Alliance, which has a 72% economic interest from KBR and was awarded a contract by the U.S. Department of Defense's TRANSCOM [2] - It is claimed that KBR misled investors about HomeSafe's ability to fulfill the Global Household Goods Contract, despite knowing of TRANSCOM's concerns [3] Group 2 - On June 19, 2025, HomeSafe announced a notice to terminate the Global Household Goods Contract, revealing ongoing issues with TRANSCOM [4] - Following the announcement, KBR's stock price dropped by $3.85 (7.29%) to close at $48.93 on June 20, 2025, and further fell by $1.30 (2.65%) to close at $47.63 on June 23, 2025 [4] - Shareholders interested in leading the class action must submit their papers by November 18, 2025, and can remain absent class members if they choose not to participate [5]
CYTK Investor Alert: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Cytokinetics, Inc.
Globenewswire· 2025-09-19 20:04
Core Viewpoint - A class action lawsuit has been filed against Cytokinetics, Inc. for allegedly misleading investors regarding the New Drug Application (NDA) submission timeline for aficamten, which may have resulted in financial losses for shareholders [2]. Group 1: Company Overview - Cytokinetics, Inc. is a biopharmaceutical company focused on developing first-in-class muscle activators and next-in-class muscle inhibitors aimed at treating diseases that compromise muscle performance [1]. Group 2: Allegations and Legal Proceedings - The lawsuit claims that during the class period from December 27, 2023, to May 6, 2025, Cytokinetics made materially false statements about the expected approval timeline for aficamten's NDA, which was anticipated in the second half of 2025 based on a PDUFA date of September 26, 2025 [2]. - The company allegedly failed to disclose significant risks related to its submission of a Risk Evaluation and Mitigation Strategy, which could delay the regulatory process [2]. - Shareholders experienced financial losses when the true situation regarding the NDA submission was revealed [2]. Group 3: Participation in Class Action - Shareholders interested in serving as lead plaintiffs must submit their papers by November 17, 2025, and can choose to remain absent class members if they do not wish to participate [3].
Did you lose money in VFC? Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against V.F.
Globenewswire· 2025-09-18 00:13
Core Viewpoint - A class action lawsuit has been filed against V.F. Corporation (VFC) for allegedly misleading investors about the company's business prospects, particularly regarding the Vans brand turnaround efforts [2][4]. Group 1: Allegations and Misleading Information - The complaint alleges that VFC misled investors about its plans to rebuild the Vans brand, including positive results from an inventory reset and new leadership appointments, while concealing the need for further significant reset actions to achieve growth [2]. - Defendants reportedly highlighted sequential revenue growth in the Vans brand but failed to disclose material adverse facts about the true state of VFC's turnaround plans [2]. Group 2: Financial Impact and Stock Performance - On May 21, 2025, VFC reported a decline in Vans' growth trajectory, with losses increasing from 8% in Q3 to 20% in Q4, and projected continued declines [3]. - Following this announcement, VFC's stock price dropped from $14.43 per share on May 20, 2025, to $12.15 per share on May 21, 2025, representing a decrease of approximately 15.8% [3]. Group 3: Class Action Participation - Shareholders interested in participating in the class action must submit their papers by November 12, 2025, to serve as lead plaintiff, representing other class members [4]. - Shareholders can remain absent class members and still be eligible for recovery without participating in the case [4].
Do You Own FLR Stock? Robbins LLP Informs Investors of the Fluor Corporation Class Action Lawsuit
Prnewswire· 2025-09-17 00:57
Core Viewpoint - A class action lawsuit has been filed against Fluor Corporation for allegedly misleading investors regarding its business prospects and financial guidance during a specific period in 2025 [1][2]. Group 1: Allegations and Financial Impact - The lawsuit claims that Fluor failed to disclose rising costs associated with major projects due to subcontractor design errors, price increases, and scheduling delays [2]. - It is alleged that these issues, along with reduced capital spending from customers and economic uncertainty, significantly impacted Fluor's business and financial results [2]. - Following the release of disappointing financial results for Q2 2025, Fluor revised its financial outlook for FY 2025, projecting adjusted EBITDA of $475 million to $525 million, down from $575 million to $675 million, and adjusted EPS of $1.95 to $2.15, down from $2.25 to $2.75 [3]. Group 2: Stock Price Reaction - After the negative financial disclosures, Fluor's stock price dropped by $15.35 per share, or 27.04%, closing at $41.42 per share on August 1, 2025 [3]. Group 3: Class Action Participation - Shareholders who wish to participate in the class action must submit their papers by November 14, 2025, to serve as lead plaintiff [4]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [4]. Group 4: Legal Representation - Robbins LLP operates on a contingency fee basis, meaning shareholders incur no fees or expenses unless the case is won [5]. - The firm has a history of advocating for shareholder rights and holding company executives accountable since 2002 [5].
Did You Lose Money in FLYE? Shareholders Who Lost Money in FLYE Should Contact Robbins LLP for Information About the Fly-E Group, Inc. Class Action Lawsuit
Prnewswire· 2025-09-17 00:50
Core Viewpoint - A class action lawsuit has been filed against Fly-E Group, Inc. for allegedly misleading investors about its revenue projections and sales performance during a specific period in 2025 [1][2]. Group 1: Allegations and Misleading Information - The lawsuit claims that Fly-E Group's management created a false impression of having reliable information regarding the company's revenue outlook and sales expectations [2]. - It is alleged that the company downplayed risks associated with lithium batteries, supply chain changes, and regulatory challenges while promoting its brand reputation and cost reductions as key growth factors [2]. Group 2: Financial Performance and Impact - On August 14, 2025, Fly-E filed a notification with the SEC indicating a significant 32% decrease in net revenue compared to the same period in 2024, primarily due to a decline in total units sold [3]. - The decline in sales was attributed to a decrease in customer purchases of E-Bikes, linked to an increase in lithium battery explosion incidents in New York [3]. - Following the revenue announcement, Fly-E's stock price plummeted approximately 87%, from $7.76 per share to $1.00 per share within a single day [3]. Group 3: Class Action Participation - Shareholders who purchased Fly-E securities during the specified period may be eligible to participate in the class action lawsuit [4]. - Interested shareholders can contact Robbins LLP to serve as lead plaintiffs or remain as absent class members without participating in the case [4].
Did You Lose Money in LifeMD, Inc? If You Suffered Significant Financial Loss in LFMD Contact Robbins LLP for Information About Leading the LFMD Class Action Lawsuit
Prnewswire· 2025-09-16 03:34
Core Viewpoint - A class action lawsuit has been filed against LifeMD, Inc. for allegedly misleading investors about its business prospects during the period from May 7, 2025, to August 5, 2025 [1][2]. Group 1: Allegations and Misconduct - The lawsuit claims that LifeMD's management materially overstated the company's competitive position and recklessly raised its 2025 guidance without properly accounting for rising customer acquisition costs in its RexMD segment and related to obesity treatment drugs [2]. - The defendants' statements regarding LifeMD's business operations and prospects were allegedly materially false and misleading, lacking a reasonable basis throughout the relevant period [2]. Group 2: Financial Impact - Following the announcement of its second quarter 2025 results on August 5, 2025, which indicated temporary challenges in the RexMD business, LifeMD revised its full-year 2025 revenue and adjusted EBITDA guidance, leading to a significant stock price drop of $5.31 per share, or 44.8%, closing at $6.53 on August 6, 2025 [3]. Group 3: Legal Proceedings - Shareholders interested in participating as lead plaintiffs in the class action must file their papers with the court by October 27, 2025 [4]. - The lead plaintiff will represent other class members in directing the litigation, although participation is not required to be eligible for recovery [4]. Group 4: Company Background - Robbins LLP, the law firm handling the case, has been dedicated to helping shareholders recover losses and improve corporate governance since 2002 [5].
Investor Alert: Robbins LLP Informs Investors of the V.F. Corporation Class Action Lawsuit
Prnewswire· 2025-09-15 20:55
Core Viewpoint - A class action lawsuit has been filed against V.F. Corporation (NYSE: VFC) for allegedly misleading investors about the company's business prospects, particularly regarding the Vans brand turnaround efforts [1][2]. Group 1: Allegations and Misleading Information - The lawsuit claims that V.F. Corporation misled investors about its plans to revitalize the Vans brand, including positive results from an inventory reset and new leadership appointments, while concealing the need for further significant reset actions to achieve growth [2]. - The complaint highlights that the company reported sequential revenue growth in the Vans brand but failed to disclose material adverse facts that would impact its revenue growth trajectory [2]. Group 2: Financial Impact - On May 21, 2025, V.F. Corporation reported a decline in Vans' growth trajectory, with losses increasing from 8% in Q3 to 20% in Q4, and projected continued declines into the next quarter [3]. - Following this announcement, VFC's stock price dropped from $14.43 per share on May 20, 2025, to $12.15 per share on May 21, 2025, representing a decrease of approximately 15.8% [3]. Group 3: Class Action Participation - Shareholders interested in participating in the class action must submit their papers by November 12, 2025, to serve as lead plaintiff, representing other class members in the litigation [4]. - Shareholders can remain absent class members and still be eligible for recovery without participating in the case [4]. Group 4: About Robbins LLP - Robbins LLP is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses and improve corporate governance since 2002 [5].